Reasons for Adherence With Antihypertensive Medication

Svensson, Staffan; Kjellgren, Karin; Ahlner, Johan; Säljö, Roger

doi:10.1097/00004872-200006001-00072

Cited by 43 publications

(71 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Side effects or symptoms ascribed to medication, even if they seem of low importance, may be a reason for patients not to adhere to medication and are mentioned specifically by patients who do not believe in their treatment [12]. Exclusion of the subgroup of patients with 'supposed adverse effects' from the analyses of non-adherence did not reproduce the previous finding that adherence of patients on 300 mg of aspirin was worse than that of patients on 30 mg.…”

Section: Discussionmentioning

confidence: 70%

“…Many studies have investigated which variables predict treatment adherence in general, but neither socioeconomic nor pathology-related factors were found to be consistent predictors [15]. Besides, several other factors have been found to contribute to non-adherence: the doctor-patient relationship, patients' unresolved concerns, the fear of adverse effects, and the patients' own beliefs about medication and medicine in general [10,12,15]. Common causes of non-adherence are often attributed to the complexity of the treatments and poor communication, especially in elderly patients with memory disorders [2].Accordingly, in this study age was an important determinant of non-adherence.…”

Section: Discussionmentioning

confidence: 99%

“…■ Key words adherence · stroke · prevention · secondary · compliance Side effects or symptoms ascribed to medication, general dislike of medication or the notion that therapy was not necessary have been reported as reasons for non-adherence for patients with antihypertensive medication [12]. Accordingly, many psychological or socioeconomical factors have been related to non-adherence in general, but no consistent predictors could be established [15].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Non–adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke

et al. 2005

View full text Add to dashboard Cite

As found in the literature on nonadherence in general, age of >or= 65 years and a higher dose of aspirin (300 mg versus 30 mg) were independently associated with non-adherence with aspirin treatment that was prescribed for secondary prevention after cerebral ischaemia of arterial origin. Older patients may require extra encouragement to continue antithrombotic treatment. Lower doses of aspirin may improve treatment adherence.

show abstract

Section: Discussionmentioning

confidence: 70%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Non–adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke

et al. 2005

View full text Add to dashboard Cite

show abstract

“…Patients' adherence to prescribed anti-hypertensive medication has been notoriously poor [9]. It has been estimated that 30-55% of hypertensive patients do not adhere to their prescribed regimen [2].…”

Section: Introductionmentioning

confidence: 99%

“…It has been estimated that 30-55% of hypertensive patients do not adhere to their prescribed regimen [2]. Exploring patients' illness experiences and providing information which they understand, may improve their adherence [9][10][11]. However, relatively little is known of hypertensive patients' perspectives on the management of their illness and their views on concordance.…”

Section: Introductionmentioning

confidence: 99%

The journey to concordance for patients with hypertension: a qualitative study in primary care

et al. 2007

View full text Add to dashboard Cite

Participants indicated a willingness to be involved in concordance in prescribing anti- hypertensive medication but needed health professionals to address their concerns and confusion about the nature of hypertension. These findings suggest that there is a need for doctors and other healthcare professionals with responsibility for prescribing to develop skills specifically to explore the beliefs and views underlying an individual's medication use. Such skills may need to be developed through specific training programmes at both undergraduate and postgraduate level.

show abstract

Effects of Benefits and Harms on Older Persons' Willingness to Take Medication for Primary Cardiovascular Prevention

Fried¹,

Tinetti²,

Towle³

et al. 2011

Arch Intern Med

129

125

View full text Add to dashboard Cite

Background Quality-assurance initiatives encourage adherence to evidenced-based guidelines based on a consideration of treatment benefit. The objective of this study was to examine older persons’ willingness to take medication for primary cardiovascular disease prevention according to benefits and harms. Methods In-person interviews were performed with 356 community-living older persons. Participants were asked about their willingness to take medication for primary prevention of myocardial infarction (MI) with varying benefits in terms of absolute 5-year risk reduction and varying harms in terms of type and severity of adverse effects. Results A majority (88%) would take medication providing an absolute benefit of six fewer persons with MI out of 100, approximating the average risk reduction of currently available medications. Of participants who would not take it, 17% changed their preference if the absolute benefit was increased to ten fewer persons with MI, and, of participants who would take it, 82% remained willing if the absolute benefit was decreased to three fewer persons with MI. In contrast, large proportions (48% – 69%) were unwilling or uncertain about taking medication with average benefit causing mild fatigue, nausea, or fuzzy thinking, and only 3% would take medication with adverse effects severe enough to affect functioning. Conclusions Older persons’ willingness to take medication for primary cardiovascular prevention is relatively insensitive to its benefit but highly sensitive to its adverse effects. These results suggest that clinical guidelines and decisions about prescribing these medications to older persons need to place emphasis on both benefits and harms.

show abstract

Reasons for Adherence With Antihypertensive Medication

Cited by 43 publications

References 0 publications

Non–adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke

Non–adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke

The journey to concordance for patients with hypertension: a qualitative study in primary care

Effects of Benefits and Harms on Older Persons' Willingness to Take Medication for Primary Cardiovascular Prevention

Contact Info

Product

Resources

About